论文信息 - Abstract 100: Novel selective PI3Kγ inhibitor AZD3458 promotes anti-tumor immune responses and reverts resistance to immunotherapy in checkpoint blockade refractory preclinical models - 字舞流文

Abstract 100: Novel selective PI3Kγ inhibitor AZD3458 promotes anti-tumor immune responses and reverts resistance to immunotherapy in checkpoint blockade refractory preclinical models

S. Barry | Cristina Gardelli | T. Klinowska | Molly A. Taylor | M. Moschetta | Adina M. Hughes | L. Carnevalli | M. King | P. M. Gutierrez | A. R. Montoya | Danielle Carrol